Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9262
Title: | Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3b and phosphorylated AKT expression levels |
Authors: | -Rong Jheng, Jia -Fan Hsieh, Chung -Hsiu Chang, Yu -Yuan Ho, Jin Fang Tang, Wen- Chen, Zi-Yi -Jou Liu, Chien |
Keywords: | Akt; GSK3b; Influenza virus A; Rosmarinic acid; Signaling pathways |
Issue Date: | 1-Aug-2022 |
Publisher: | Elsevier Taiwan LLC |
Abstract: | Abstract Background: The purpose of this study was to examine the in vivo activity of rosmarinic acid (RA) e a phytochemical with antioxidant, anti-inflammatory, and antiviral properties e against influenza virus (IAV). An antibody-based kinase array and different in vitro functional assays were also applied to identify the mechanistic underpinnings by which RA may exert its anti-IAV activity.Methods: We initially examined the potential efficacy of RA using an in vivo mouse model. A time-of-addition assay and an antibody-based kinase array were subsequently applied to investigate mechanism-of-action targets for RA. The hemagglutination inhibition assay, neuraminidase inhibition assay, and cellular entry assay were also performed. Results: RA increased survival and prevented body weight loss in IAV-infected mice. In vitro experiments revealed that RA inhibited different IAV viruses e including oseltamivirresistant strains. From a mechanistic point of view, RA downregulated the GSK3b and Akt signaling pathways e which are known to facilitate IAV entry and replication into host cells. Conclusions: RA has promising preclinical efficacy against IAV, primarily by interfering with the GSK3b and Akt signaling pathways. |
URI: | http://localhost:8080/xmlui/handle/123456789/9262 |
ISSN: | 1684-1182 |
Appears in Collections: | VOL 55 NO 4 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
598-610.pdf | 2.11 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.